Post

Syneos Health (Morrisville, NC) — biopharmaceutical CRO + commercialization. 2024 revenue ~$5.4B. Merged InVentiv + INC Research (2017). Clinical development, late-phase, and commercial deployment.

12:41:32 AM · Jul 9, 2026
Sign in to reply and join the conversation.